Silencing of BCR/ABL Chimeric Gene in Human Chronic Myelogenous Leukemia Cell Line K562 by siRNA-Nuclear Export Signal Peptide Conjugates.

Nucleic Acid Ther 2017 Jun 29;27(3):168-175. Epub 2017 Mar 29.

1 Department of Biological and Environmental Chemistry, School of Humanity Oriented Science and Technology, Kindai University , Iizuka, Japan .

Herein we described the synthesis of siRNA-NES (nuclear export signal) peptide conjugates by solid phase fragment coupling and the application of them to silencing of bcr/abl chimeric gene in human chronic myelogenous leukemia cell line K562. Two types of siRNA-NES conjugates were prepared, and both sense strands at 5' ends were covalently linked to a NES peptide derived from TFIIIA and HIV-1 REV, respectively. Significant enhancement of silencing efficiency was observed for both of them. siRNA-TFIIIA NES conjugate suppressed the expression of BCR/ABL gene to 8.3% at 200 nM and 11.6% at 50 nM, and siRNA-HIV-1REV NES conjugate suppressed to 4.0% at 200 nM and 6.3% at 50 nM, whereas native siRNA suppressed to 36.3% at 200 nM and 30.2% at 50 nM. We could also show complex of siRNA-NES conjugate and designed amphiphilic peptide peptideβ7 could be taken up into cells with no cytotoxicity and showed excellent silencing efficiency. We believe that the complex siRNA-NES conjugate and peptideβ7 is a promising candidate for in vivo use and therapeutic applications.

Download full-text PDF

Source
http://dx.doi.org/10.1089/nat.2016.0647DOI Listing
June 2017
15 Reads

Publication Analysis

Top Keywords

peptide conjugates
8
chronic myelogenous
8
sirna-nes conjugate
8
myelogenous leukemia
8
complex sirna-nes
8
cell k562
8
silencing efficiency
8
leukemia cell
8
human chronic
8
nes conjugate
8
bcr/abl chimeric
8
signal peptide
8
silencing bcr/abl
8
conjugate suppressed
8
chimeric gene
8
gene human
8
export signal
8
expression bcr/abl
4
83% 200 nm
4
sirna-hiv-1rev nes
4

Similar Publications